Spirobrorphine

Spirobrorphine
Identifiers
  • 8-[1-(4-bromophenyl)ethyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one
PubChem CID
ChemSpider
Chemical and physical data
FormulaC21H24BrN3O
Molar mass414.347 g·mol−1
3D model (JSmol)
  • CC(C1=CC=C(C=C1)Br)N2CCC3(CC2)C(=O)NCN3C4=CC=CC=C4
  • InChI=1S/C21H24BrN3O/c1-16(17-7-9-18(22)10-8-17)24-13-11-21(12-14-24)20(26)23-15-25(21)19-5-3-2-4-6-19/h2-10,16H,11-15H2,1H3,(H,23,26)
  • Key:BKVHJNVMUACENG-UHFFFAOYSA-N

Spirobrorphine is a synthetic opioid chemical compound which has been sold as a designer drug, first reported in the USA in February 2026. It was added to the controlled drug schedules in Canada in June 2026. Its pharmacology has not yet been studied but it is believed to be a potent opioid narcotic in a similar manner to related compounds such as spirochlorphine and R6372.

See also

References

  1. ↑ "Emerging Global Synthetic Opioid Threats: Benzimidazol-2-ones – The Orphines. Colombo Plan Health Alert, February 2026" (PDF). www.cfsre.org.
  2. ↑ "Order Amending Schedule V to the Controlled Drugs and Substances Act (R 29676, Spirobrorphine and Spirochlorphine): SOR/2026-71. Canada Gazette, Part II, Volume 160, Number 9. 17 April 2026". gazette.gc.ca. Government of Canada, Public Works and Government Services Canada, Integrated Services Branch, Canada Gazette.